Medical case reports suggest that cannabinoids extracted from Cannabis sativa have
therapeutic effects; however, the therapeutic employment is limited due to the psychotropic …

The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …

Given the abundancy of angiotensin converting enzyme 2 (ACE‐2) receptors density,
beyond the lung, the intestine is considered as an alternative site of infection and replication …

Concomitant use of cannabis with other drugs may lead to cannabis–drug interactions,
mainly due to the pharmacokinetic mechanism involving the family of CYP450 isoenzymes …

The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for
new options for both causal treatment and mitigation of its symptoms. Scientists and …

Cannabis sativa L. has been one of the oldest medicinal plants cultivated for 10,000 years
for several agricultural and industrial applications. However, the plant became controversial …

During the COVID-19 pandemic lasting now for well more than a year, nearly 247 million
cases have been diagnosed and over 5 million deaths have been recorded worldwide as of …

The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas gene editing
technology has opened a new era of genome interrogation and genome engineering …

Importance: Owing to its anti-inflammatory properties and antiviral “in vitro” effect against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cannabidiol (CBD) has …

The interaction between cannabis use or addiction and SARS-COV-2 infection rates and
COVID-19 outcomes is obscure. As of 08/01/2022 among 57 evaluated epidemiological …